BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.4 EUR | +1.88% |
|
+4.08% | -18.53% |
| 04-26 | Bayer CEO wins first AGM shareholder vote | RE |
| 04-26 | BAYER SAYS INVESTORS WITH 91.69% OF EQUITY CAPITAL REPRESENTED A… | RE |
| Sales 2024 * | 47.11B 50.37B 4,034B | Sales 2025 * | 47.96B 51.28B 4,107B | Capitalization | 26.92B 28.78B 2,305B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.08B 2.23B 178B | Net income 2025 * | 3.17B 3.39B 271B | EV / Sales 2024 * | 1.27 x |
| Net Debt 2024 * | 33.11B 35.4B 2,835B | Net Debt 2025 * | 29.67B 31.72B 2,540B | EV / Sales 2025 * | 1.18 x |
| P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
8.43
x | Employees | 96,931 |
| Yield 2024 * |
0.4% | Yield 2025 * |
0.85% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
| 1 day | +1.88% | ||
| 1 week | +4.08% | ||
| Current month | -3.62% | ||
| 1 month | +0.31% | ||
| 3 months | -15.21% | ||
| 6 months | -32.78% | ||
| Current year | -18.53% |
1 week
26.72
27.70
1 month
25.6128.94
Current year
24.9636.09
1 year
24.9660.15
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 31/03/23 |
| Director of Finance/CFO | 54 | 25/04/18 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 31/03/17 |
| Director/Board Member | 68 | 31/03/17 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 31/03/21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 27.4 | +1.88% | 4,690,278 |
| 25/04/24 | 26.9 | -0.28% | 3,533,816 |
| 24/04/24 | 26.97 | -1.37% | 2,710,724 |
| 23/04/24 | 27.34 | +0.11% | 3,055,329 |
| 22/04/24 | 27.32 | +3.76% | 4,999,901 |
Delayed Quote Xetra, April 26, 2024 at 04:39 pm
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
28/04/2024
- Ex-dividend day for final dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.4
EUR
Average target price
36.9
EUR
Spread / Average Target
+34.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.53% | 28.74B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- BAYN Stock
